Literature DB >> 24581596

Hepatic steatosis is associated with increased hepatic FDG uptake.

Georgia Keramida1, Jon Potts2, Janice Bush3, Sabina Dizdarevic4, A Michael Peters4.   

Abstract

OBJECTIVE: The use of liver as a reference tissue for semi-quantification of tumour FDG uptake may not be valid in hepatic steatosis (HS). Previous studies on the relation between liver FDG uptake and HS have been contradictory probably because they ignored blood glucose (BG). Because hepatocyte and blood FDG concentrations equalize, liver FDG uptake parallels BG, which must therefore be considered when studying hepatic FDG uptake. We therefore re-examined the relation between HS and liver uptake taking BG into account.
METHODS: This was a retrospective study of 304 patients undergoing routine PET/CT with imaging 60min post-FDG. Average standard uptake value (SUVave), maximum SUV (SUVmax) and CT density (index of HS) were measured in a liver ROI. Blood pool SUV was based on the left ventricular cavity (SUVLV). Correlations were assessed using least squares fitting of continuous data. Patients were also divided into BG subgroups (<4, 4-5, 5-6, 6-8, 8-10 and 10+mmol/l).
RESULTS: SUVave, SUVmax and SUVLV displayed similar relations with BG. SUVmax/SUVLV, but not SUVave/SUVLV, correlated significantly with BG. SUVmax, but not SUVave, correlated inversely with CT density before and after adjusting for BG. SUVmax/SUVave correlated more strongly with CT density than SUVmax. CT density correlated inversely with SUVmax/SUVLV but positively with SUVave/SUVLV.
CONCLUSIONS: Hepatic SUV is more influenced by BG than by HS. Its relation with BG renders it unsuitable as a reference tissue. Nevertheless, hepatic fat does correlate positively with liver SUV, although this is seen only with SUVmax because SUVave is 'diluted' by hepatic fat.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FDG; Glucose; Hepatic steatosis; Standard uptake value

Mesh:

Substances:

Year:  2014        PMID: 24581596     DOI: 10.1016/j.ejrad.2014.01.027

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  16 in total

1.  The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy.

Authors:  Xingchen Wu; Abhisek Bhattarai; Pasi Korkola; Hannu Pertovaara; Hannu Eskola; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

2.  Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Authors:  A Michael Peters; Georgia Keramida; Deborah Pencharz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-17       Impact factor: 9.236

3.  Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function.

Authors:  Guobao Wang; Michael T Corwin; Kristin A Olson; Ramsey D Badawi; Souvik Sarkar
Journal:  Phys Med Biol       Date:  2018-07-24       Impact factor: 3.609

4.  Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.

Authors:  Seung Hwan Moon; Sun-Pyo Hong; Young Seok Cho; Tae Soo Noh; Joon Young Choi; Byung-Tae Kim; Kyung-Han Lee
Journal:  J Nucl Cardiol       Date:  2015-10-28       Impact factor: 5.952

5.  Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT.

Authors:  X Yue; J Wang; F Ye; D Xiao
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

6.  Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Authors:  Osamu Manabe; Markus Kroenke; Tadao Aikawa; Atsuto Murayama; Masanao Naya; Atsuro Masuda; Noriko Oyama-Manabe; Kenji Hirata; Shiro Watanabe; Tohru Shiga; Chietsugu Katoh; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-12-14       Impact factor: 5.952

7.  Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Authors:  Georgia Keramida; Sabina Dizdarevic; Janice Bush; A Michael Peters
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

8.  New exponential functions based on CT density to estimate the percentage of liver that is fat.

Authors:  Georgia Keramida; A Michael Peters
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

9.  Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation.

Authors:  Yang Zuo; Souvik Sarkar; Michael T Corwin; Kristin Olson; Ramsey D Badawi; Guobao Wang
Journal:  Phys Med Biol       Date:  2019-09-05       Impact factor: 3.609

10.  Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.

Authors:  Dasiuke Izumi; Naoya Yoshida; Masayuki Watanabe; Shinya Shiraishi; Takatsugu Ishimoto; Keisuke Kosumi; Ryuma Tokunaga; Katsunobu Taki; Takaaki Higashi; Kazuto Harada; Tatsunori Miyata; Satoshi Ida; Yu Imamura; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-12-15       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.